ALFA Finder| Management target | Revenue 23.5% FY27 |
|---|
| Revenue growth | 20% YoY reaching ₹737 Cr in Q1 FY27. |
|---|---|
| Margins | CM at 72.3%; EBITDA margin at 17% due to growth investments. |
| Demand visibility | Strong broad-based momentum across all business segments. |
| Management confidence | High; conviction to deliver 21-23.5% full-year growth. |
Growth
Revenue reached ₹737 Cr (up 20% YoY); Profit After Tax jumped 4x YoY to ₹20 Cr.
Outlook
Full-year FY27 revenue guidance of 21-23.5%; ETR expected to normalize to 28-30% for the fiscal year.
Risks
Lower contribution margins due to mix shift towards distribution and high Q1 effective tax rate of 48%.
Last quarter's promises, checked
Delivered
- Guided Q1 FY27 revenue growth at lower end of 21-23.5% → delivered 20% (= PARTIAL)
- Guided 500 bps EBITDA margin improvement in FY26 → delivered 500 bps (= BEAT)
- Guided FY26 operating cash flow at ₹395 Cr → delivered ₹395 Cr (= BEAT)
Partly delivered
- Guided FY27 revenue growth 21-23.5% → Q1 actual 20% (= PARTIAL)
Investor Presentation filed with BSE, NSE: PINELABS. Summary written with AI assistance from the document.
Pine Labs Ltd: key numbers
- Share price
- ₹176.44
- Market cap
- ₹20,374 Cr
- Revenue (annual)
- ₹2,711 Cr
- Net profit (annual)
- ₹112.5 Cr
- P/E (TTM)
- 127.4×Sector 23.7×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 13.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Pine Labs Ltd
All →Pine Labs Other Announcement
Pine Labs Limited filed CARE Ratings' Monitoring Agency Report for the quarter ended September 30, 2026, on its IPO proceeds. The report shows no deviation from objects and no major deviations.
Pine Labs Investor Presentation: Key Takeaways
Q2 FY27: Revenue ₹806 Cr (+24% YoY), Adj EBITDA ₹155 Cr (19% margin), PAT ₹39 Cr (6x YoY). Investing in mid-market, international and UPI.
Pine Labs Q2 FY27 Results: Net Profit ₹38.6 Cr, Up 543.3% YoY
Pine Labs Ltd reported revenue from operations of ₹806.2 Cr (+24.0% YoY) and net profit of ₹38.6 Cr (+543.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹38.6 Cr · +543.3% YoY
Pine Labs Employee Stock Options
Pine Labs granted 16,37,152 employee stock options under its ESOP 2025 scheme. Options vest over 48 months at exercise prices of Rs 5.40 to Rs 150.06.
Pine Labs Acquisition Worth ₹25 Cr
Pine Labs Limited invested ₹24.9993 Crore in its wholly owned subsidiary, Synergistic Financial Networks Private Limited, via a rights issue subscription.
- Value
- ₹25.00 Cr
Pine Labs Board Meeting Date
Pine Labs Limited scheduled a board meeting on October 29, 2026, to consider financial results, followed by an earnings conference call.